| Popis: |
Basal cell carcinoma (BCC) is the most prevalent malignancy in the world, particularly among people with fair skin. These cancers, along with squamous cell carcinoma (SCC), are classified as non-melanoma skin cancers (NMSC), with 18 to 20 times the incidence of melanoma. 80% of non-melanoma skin cancer (NMSC) is BCC and 20% is SCC. Incidence rates of basal cell carcinomas (BCCs) have increased by 3–10% per year annually over the past decade, and this trend is expected to continue due to increased life expectancy and ultraviolet radiation exposure. Sun exposure plays a role in the development and transformation of basal cell carcinoma (BCC). As expected, patients with light skin phenotypes, such as those with blue eyes, red hair, and freckling, as well as those whose occupation or leisure activities result in intense and prolonged sun exposure, are especially susceptible. The progression of BCC can result in the devastation and disfigurement of nearby tissues. About 85–90% of BCC cases occur on the cranium, significantly altering the facial appearance of the patient. BCCs are still primarily treated surgically. It can be difficult to remove massive facial tumors with an appropriate margin while preserving function and aesthetics. In addition, complex reconstruction techniques, such as free flaps or multiple local flaps, are required. |
